November 26, 2014 3:36 PM ET

Biotechnology

Company Overview of Ambit Biosciences Corporation

Key Executives for Ambit Biosciences Corporation

NameBoard RelationshipsTitleAge
Michael A. Martino 4 RelationshipsChief Executive Officer and President57
David J. Austin Ph.D.No RelationshipsCo-Founder, Chairman of Scientific Advisory Board--
Kevin J. Kinsella 42 RelationshipsFounder68
Alan Fuhrman 8 RelationshipsChief Financial Officer and Principal Accounting Officer57
Athena Countouriotis M.D.No RelationshipsChief Medical Officer42
View More Key Executives

Ambit Biosciences Corporation Board Members*

NameBoard RelationshipsPrimary CompanyAge
David Armistead Ph.D. 43 RelationshipsEnsemble Therapeutics Corporation--
Edward Roberts Ph.D., B.Sc 70 RelationshipsReceptos, Inc.--
Webster K. Cavenee Ph.D. 29 RelationshipsVioQuest Pharmaceuticals Inc.--
Tony Hunter Ph.D. 33 RelationshipsUniversity of Cambridge--
Brian J. Druker M.D. 151 RelationshipsMolecularMD Corp.--
View All Board Members

Ambit Biosciences Corporation Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$440.1K
440.1K
361.7K
Bonus
Not meaningful
Total Short Term Compensation$440.1K
440.1K
436.3K
Total Value of Options
21.4M
Compensation as of Fiscal Year
Ambit Biosciences Corporation CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Harbinger Group Inc. Announces Management Changes
November 25, 2014 2:30 PM ET
Kimberly-Clark Corporation Announces Resignation of Robert E. Abernathy as President, Global Health
November 05, 2014 1:01 PM ET
Armored AutoGroup, Inc. Announces Management Changes
November 03, 2014 3:13 PM ET
Church & Dwight Co. Inc. Appoints Matthew T. Farrell as Chief Operating Officer and Chief Financial Officer
November 03, 2014 12:00 PM ET
Vinda International Holdings Limited Appoints WONG Kwai Huen, Albert, as a Member of the Audit Committee and Nomination Committee
November 03, 2014 5:37 AM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ambit Biosciences Corporation, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.